Joachim Labenz

Joachim Labenz

Department Of Internal Medicine And Gastroenterology, Elisabeth Hospital, Essen, Germany And Department Of Gastroenterology, Meath/adelaide Hospitals, Trinity College, Dublin, Ireland

Direct Impact

Concepts for which Joachim Labenz has direct influence:

rescue therapy
pylori infection
endostim stimulation
multicenter phase
esomeprazole gerd
chondroitin sulphate
hyaluronic acid

Prominent publications by Joachim Labenz


KOL-Index: 10 On the basis of the overwhelming results of intervention trials, eradication therapy is now strongly recommended in all peptic ulcer patients infected with Helicobacter pylori. Also, arguments exist for treating H. pylori-positive patients with functional dyspepsia. Triple therapy with bismuth or an antisecretory drug plus two antibiotics is highly effective, but complicated regimens and ...
Known for
Omeprazole Clarithromycin
KOL-Index: 2 The purpose of the study is to determine whether a maintenance treatment over 12 weeks with esomeprazole 20 mg daily will sufficiently give control over GERD symptoms and how it compares either with an on-demand therapy with esomeprazole 20 mg or an as needed therapy (wait and see regimen) with rescue medication only (antacid), following a 4-weeks acute treatment phase with either ...
Known for
Symptoms Compares | Esomeprazole Determine | Acute Phase | Rescue Medication
KOL-Index: 2 To provide a research tool enabling physicians to monitor long term clinical outcomes for patients undergoing gastroesophageal reflux disease (GERD) treatment with EndoStim LES Stimulation System. Detailed Description The EndoStim Patient Registry provides a framework for data collection on patients with GERD treated with the EndoStim LES Stimulation System. The primary objective is to ...
KOL-Index: 2 This is a post-market, multi-center, double-blind, placebo-controlled, randomized, cross-over study with GERDOff Plus added on top of the current PPI treatment in patients with GERD. The aim of the study is to evaluate the performance of GERDOff Plus, a class III medical device, consisting in a hyaluronic acid, chondroitin sulphate and magnesium trisilicate, in addition to the PPIs, in ...
KOL-Index: 2 Successful H. pylori eradication therapy remains a challenge in medical practice. Despite promising data for first-line, second-line and rescue treatment options based on clinical trials as well as guidelines and expert recommendations, success rates can often not be reproduced in general practice. Rescue options for patients with failed initial or second-line therapy are definitely needed. ...
Known for
Excitatory Effects | Optimal Duration | Broad Antibacterial | Potential Candidates

Department of Internal Medicine and Gastroenterology, Elisabeth Hospital, Essen, Germany and Department of Gastroenterology, Meath/Adelaide Hospitals, Trinity College, Dublin, Ireland

© 2022 - Key Opinion Leaders -
Key Opinion Leaders, LLC ,
2025 NW 102 Avenue, Suite 111 Doral , FL   33172